Global Efavirenz API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Efavirenz(CAS?154598-52-4) is an antiretroviral medication used to treat and prevent HIV/AIDS.
LPI (LP Information)' newest research report, the “Efavirenz API Industry Forecast” looks at past sales and reviews total world Efavirenz API sales in 2022, providing a comprehensive analysis by region and market sector of projected Efavirenz API sales for 2023 through 2029. With Efavirenz API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Efavirenz API industry.
This Insight Report provides a comprehensive analysis of the global Efavirenz API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Efavirenz API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Efavirenz API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Efavirenz API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Efavirenz API.
The global Efavirenz API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Efavirenz API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Efavirenz API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Efavirenz API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Efavirenz API players cover Acebright India Pharma Private Limited, Arene Lifesciences Limited, Dasami Lab, Gonane Pharma, Hetero Drugs, Laurus Labs, Mylan, NEWEDGE Overseas and SMS Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Efavirenz API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Efavirenz API market?
What factors are driving Efavirenz API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Efavirenz API market opportunities vary by end market size?
How does Efavirenz API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Efavirenz(CAS?154598-52-4) is an antiretroviral medication used to treat and prevent HIV/AIDS.
LPI (LP Information)' newest research report, the “Efavirenz API Industry Forecast” looks at past sales and reviews total world Efavirenz API sales in 2022, providing a comprehensive analysis by region and market sector of projected Efavirenz API sales for 2023 through 2029. With Efavirenz API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Efavirenz API industry.
This Insight Report provides a comprehensive analysis of the global Efavirenz API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Efavirenz API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Efavirenz API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Efavirenz API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Efavirenz API.
The global Efavirenz API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Efavirenz API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Efavirenz API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Efavirenz API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Efavirenz API players cover Acebright India Pharma Private Limited, Arene Lifesciences Limited, Dasami Lab, Gonane Pharma, Hetero Drugs, Laurus Labs, Mylan, NEWEDGE Overseas and SMS Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Efavirenz API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Above 98 %
- Above 99 %
- Oral Solution
- Capsules
- Tablets
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Acebright India Pharma Private Limited
- Arene Lifesciences Limited
- Dasami Lab
- Gonane Pharma
- Hetero Drugs
- Laurus Labs
- Mylan
- NEWEDGE Overseas
- SMS Pharmaceuticals
- Mangalam Drugs & Organics Ltd
- Shanghai Desano Bio-Pharmaceutical
- Guangzhou Topwork Chemical
- Jiangsu Zhongbang Pharmaceutical
- Nortec Quimica
- Globe Quimica Ltda
What is the 10-year outlook for the global Efavirenz API market?
What factors are driving Efavirenz API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Efavirenz API market opportunities vary by end market size?
How does Efavirenz API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Efavirenz API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Efavirenz API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Efavirenz API by Country/Region, 2018, 2022 & 2029
2.2 Efavirenz API Segment by Type
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Efavirenz API Sales by Type
2.3.1 Global Efavirenz API Sales Market Share by Type (2018-2023)
2.3.2 Global Efavirenz API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Efavirenz API Sale Price by Type (2018-2023)
2.4 Efavirenz API Segment by Application
2.4.1 Oral Solution
2.4.2 Capsules
2.4.3 Tablets
2.4.4 Others
2.5 Efavirenz API Sales by Application
2.5.1 Global Efavirenz API Sale Market Share by Application (2018-2023)
2.5.2 Global Efavirenz API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Efavirenz API Sale Price by Application (2018-2023)
3 GLOBAL EFAVIRENZ API BY COMPANY
3.1 Global Efavirenz API Breakdown Data by Company
3.1.1 Global Efavirenz API Annual Sales by Company (2018-2023)
3.1.2 Global Efavirenz API Sales Market Share by Company (2018-2023)
3.2 Global Efavirenz API Annual Revenue by Company (2018-2023)
3.2.1 Global Efavirenz API Revenue by Company (2018-2023)
3.2.2 Global Efavirenz API Revenue Market Share by Company (2018-2023)
3.3 Global Efavirenz API Sale Price by Company
3.4 Key Manufacturers Efavirenz API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Efavirenz API Product Location Distribution
3.4.2 Players Efavirenz API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR EFAVIRENZ API BY GEOGRAPHIC REGION
4.1 World Historic Efavirenz API Market Size by Geographic Region (2018-2023)
4.1.1 Global Efavirenz API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Efavirenz API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Efavirenz API Market Size by Country/Region (2018-2023)
4.2.1 Global Efavirenz API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Efavirenz API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Efavirenz API Sales Growth
4.4 APAC Efavirenz API Sales Growth
4.5 Europe Efavirenz API Sales Growth
4.6 Middle East & Africa Efavirenz API Sales Growth
5 AMERICAS
5.1 Americas Efavirenz API Sales by Country
5.1.1 Americas Efavirenz API Sales by Country (2018-2023)
5.1.2 Americas Efavirenz API Revenue by Country (2018-2023)
5.2 Americas Efavirenz API Sales by Type
5.3 Americas Efavirenz API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Efavirenz API Sales by Region
6.1.1 APAC Efavirenz API Sales by Region (2018-2023)
6.1.2 APAC Efavirenz API Revenue by Region (2018-2023)
6.2 APAC Efavirenz API Sales by Type
6.3 APAC Efavirenz API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Efavirenz API by Country
7.1.1 Europe Efavirenz API Sales by Country (2018-2023)
7.1.2 Europe Efavirenz API Revenue by Country (2018-2023)
7.2 Europe Efavirenz API Sales by Type
7.3 Europe Efavirenz API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Efavirenz API by Country
8.1.1 Middle East & Africa Efavirenz API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Efavirenz API Revenue by Country (2018-2023)
8.2 Middle East & Africa Efavirenz API Sales by Type
8.3 Middle East & Africa Efavirenz API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Efavirenz API
10.3 Manufacturing Process Analysis of Efavirenz API
10.4 Industry Chain Structure of Efavirenz API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Efavirenz API Distributors
11.3 Efavirenz API Customer
12 WORLD FORECAST REVIEW FOR EFAVIRENZ API BY GEOGRAPHIC REGION
12.1 Global Efavirenz API Market Size Forecast by Region
12.1.1 Global Efavirenz API Forecast by Region (2024-2029)
12.1.2 Global Efavirenz API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Efavirenz API Forecast by Type
12.7 Global Efavirenz API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Acebright India Pharma Private Limited
13.1.1 Acebright India Pharma Private Limited Company Information
13.1.2 Acebright India Pharma Private Limited Efavirenz API Product Portfolios and Specifications
13.1.3 Acebright India Pharma Private Limited Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Acebright India Pharma Private Limited Main Business Overview
13.1.5 Acebright India Pharma Private Limited Latest Developments
13.2 Arene Lifesciences Limited
13.2.1 Arene Lifesciences Limited Company Information
13.2.2 Arene Lifesciences Limited Efavirenz API Product Portfolios and Specifications
13.2.3 Arene Lifesciences Limited Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Arene Lifesciences Limited Main Business Overview
13.2.5 Arene Lifesciences Limited Latest Developments
13.3 Dasami Lab
13.3.1 Dasami Lab Company Information
13.3.2 Dasami Lab Efavirenz API Product Portfolios and Specifications
13.3.3 Dasami Lab Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Dasami Lab Main Business Overview
13.3.5 Dasami Lab Latest Developments
13.4 Gonane Pharma
13.4.1 Gonane Pharma Company Information
13.4.2 Gonane Pharma Efavirenz API Product Portfolios and Specifications
13.4.3 Gonane Pharma Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Gonane Pharma Main Business Overview
13.4.5 Gonane Pharma Latest Developments
13.5 Hetero Drugs
13.5.1 Hetero Drugs Company Information
13.5.2 Hetero Drugs Efavirenz API Product Portfolios and Specifications
13.5.3 Hetero Drugs Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hetero Drugs Main Business Overview
13.5.5 Hetero Drugs Latest Developments
13.6 Laurus Labs
13.6.1 Laurus Labs Company Information
13.6.2 Laurus Labs Efavirenz API Product Portfolios and Specifications
13.6.3 Laurus Labs Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Laurus Labs Main Business Overview
13.6.5 Laurus Labs Latest Developments
13.7 Mylan
13.7.1 Mylan Company Information
13.7.2 Mylan Efavirenz API Product Portfolios and Specifications
13.7.3 Mylan Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mylan Main Business Overview
13.7.5 Mylan Latest Developments
13.8 NEWEDGE Overseas
13.8.1 NEWEDGE Overseas Company Information
13.8.2 NEWEDGE Overseas Efavirenz API Product Portfolios and Specifications
13.8.3 NEWEDGE Overseas Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 NEWEDGE Overseas Main Business Overview
13.8.5 NEWEDGE Overseas Latest Developments
13.9 SMS Pharmaceuticals
13.9.1 SMS Pharmaceuticals Company Information
13.9.2 SMS Pharmaceuticals Efavirenz API Product Portfolios and Specifications
13.9.3 SMS Pharmaceuticals Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 SMS Pharmaceuticals Main Business Overview
13.9.5 SMS Pharmaceuticals Latest Developments
13.10 Mangalam Drugs & Organics Ltd
13.10.1 Mangalam Drugs & Organics Ltd Company Information
13.10.2 Mangalam Drugs & Organics Ltd Efavirenz API Product Portfolios and Specifications
13.10.3 Mangalam Drugs & Organics Ltd Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mangalam Drugs & Organics Ltd Main Business Overview
13.10.5 Mangalam Drugs & Organics Ltd Latest Developments
13.11 Shanghai Desano Bio-Pharmaceutical
13.11.1 Shanghai Desano Bio-Pharmaceutical Company Information
13.11.2 Shanghai Desano Bio-Pharmaceutical Efavirenz API Product Portfolios and Specifications
13.11.3 Shanghai Desano Bio-Pharmaceutical Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Desano Bio-Pharmaceutical Main Business Overview
13.11.5 Shanghai Desano Bio-Pharmaceutical Latest Developments
13.12 Guangzhou Topwork Chemical
13.12.1 Guangzhou Topwork Chemical Company Information
13.12.2 Guangzhou Topwork Chemical Efavirenz API Product Portfolios and Specifications
13.12.3 Guangzhou Topwork Chemical Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Guangzhou Topwork Chemical Main Business Overview
13.12.5 Guangzhou Topwork Chemical Latest Developments
13.13 Jiangsu Zhongbang Pharmaceutical
13.13.1 Jiangsu Zhongbang Pharmaceutical Company Information
13.13.2 Jiangsu Zhongbang Pharmaceutical Efavirenz API Product Portfolios and Specifications
13.13.3 Jiangsu Zhongbang Pharmaceutical Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Jiangsu Zhongbang Pharmaceutical Main Business Overview
13.13.5 Jiangsu Zhongbang Pharmaceutical Latest Developments
13.14 Nortec Quimica
13.14.1 Nortec Quimica Company Information
13.14.2 Nortec Quimica Efavirenz API Product Portfolios and Specifications
13.14.3 Nortec Quimica Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Nortec Quimica Main Business Overview
13.14.5 Nortec Quimica Latest Developments
13.15 Globe Quimica Ltda
13.15.1 Globe Quimica Ltda Company Information
13.15.2 Globe Quimica Ltda Efavirenz API Product Portfolios and Specifications
13.15.3 Globe Quimica Ltda Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Globe Quimica Ltda Main Business Overview
13.15.5 Globe Quimica Ltda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Efavirenz API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Efavirenz API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Efavirenz API by Country/Region, 2018, 2022 & 2029
2.2 Efavirenz API Segment by Type
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Efavirenz API Sales by Type
2.3.1 Global Efavirenz API Sales Market Share by Type (2018-2023)
2.3.2 Global Efavirenz API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Efavirenz API Sale Price by Type (2018-2023)
2.4 Efavirenz API Segment by Application
2.4.1 Oral Solution
2.4.2 Capsules
2.4.3 Tablets
2.4.4 Others
2.5 Efavirenz API Sales by Application
2.5.1 Global Efavirenz API Sale Market Share by Application (2018-2023)
2.5.2 Global Efavirenz API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Efavirenz API Sale Price by Application (2018-2023)
3 GLOBAL EFAVIRENZ API BY COMPANY
3.1 Global Efavirenz API Breakdown Data by Company
3.1.1 Global Efavirenz API Annual Sales by Company (2018-2023)
3.1.2 Global Efavirenz API Sales Market Share by Company (2018-2023)
3.2 Global Efavirenz API Annual Revenue by Company (2018-2023)
3.2.1 Global Efavirenz API Revenue by Company (2018-2023)
3.2.2 Global Efavirenz API Revenue Market Share by Company (2018-2023)
3.3 Global Efavirenz API Sale Price by Company
3.4 Key Manufacturers Efavirenz API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Efavirenz API Product Location Distribution
3.4.2 Players Efavirenz API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR EFAVIRENZ API BY GEOGRAPHIC REGION
4.1 World Historic Efavirenz API Market Size by Geographic Region (2018-2023)
4.1.1 Global Efavirenz API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Efavirenz API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Efavirenz API Market Size by Country/Region (2018-2023)
4.2.1 Global Efavirenz API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Efavirenz API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Efavirenz API Sales Growth
4.4 APAC Efavirenz API Sales Growth
4.5 Europe Efavirenz API Sales Growth
4.6 Middle East & Africa Efavirenz API Sales Growth
5 AMERICAS
5.1 Americas Efavirenz API Sales by Country
5.1.1 Americas Efavirenz API Sales by Country (2018-2023)
5.1.2 Americas Efavirenz API Revenue by Country (2018-2023)
5.2 Americas Efavirenz API Sales by Type
5.3 Americas Efavirenz API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Efavirenz API Sales by Region
6.1.1 APAC Efavirenz API Sales by Region (2018-2023)
6.1.2 APAC Efavirenz API Revenue by Region (2018-2023)
6.2 APAC Efavirenz API Sales by Type
6.3 APAC Efavirenz API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Efavirenz API by Country
7.1.1 Europe Efavirenz API Sales by Country (2018-2023)
7.1.2 Europe Efavirenz API Revenue by Country (2018-2023)
7.2 Europe Efavirenz API Sales by Type
7.3 Europe Efavirenz API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Efavirenz API by Country
8.1.1 Middle East & Africa Efavirenz API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Efavirenz API Revenue by Country (2018-2023)
8.2 Middle East & Africa Efavirenz API Sales by Type
8.3 Middle East & Africa Efavirenz API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Efavirenz API
10.3 Manufacturing Process Analysis of Efavirenz API
10.4 Industry Chain Structure of Efavirenz API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Efavirenz API Distributors
11.3 Efavirenz API Customer
12 WORLD FORECAST REVIEW FOR EFAVIRENZ API BY GEOGRAPHIC REGION
12.1 Global Efavirenz API Market Size Forecast by Region
12.1.1 Global Efavirenz API Forecast by Region (2024-2029)
12.1.2 Global Efavirenz API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Efavirenz API Forecast by Type
12.7 Global Efavirenz API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Acebright India Pharma Private Limited
13.1.1 Acebright India Pharma Private Limited Company Information
13.1.2 Acebright India Pharma Private Limited Efavirenz API Product Portfolios and Specifications
13.1.3 Acebright India Pharma Private Limited Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Acebright India Pharma Private Limited Main Business Overview
13.1.5 Acebright India Pharma Private Limited Latest Developments
13.2 Arene Lifesciences Limited
13.2.1 Arene Lifesciences Limited Company Information
13.2.2 Arene Lifesciences Limited Efavirenz API Product Portfolios and Specifications
13.2.3 Arene Lifesciences Limited Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Arene Lifesciences Limited Main Business Overview
13.2.5 Arene Lifesciences Limited Latest Developments
13.3 Dasami Lab
13.3.1 Dasami Lab Company Information
13.3.2 Dasami Lab Efavirenz API Product Portfolios and Specifications
13.3.3 Dasami Lab Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Dasami Lab Main Business Overview
13.3.5 Dasami Lab Latest Developments
13.4 Gonane Pharma
13.4.1 Gonane Pharma Company Information
13.4.2 Gonane Pharma Efavirenz API Product Portfolios and Specifications
13.4.3 Gonane Pharma Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Gonane Pharma Main Business Overview
13.4.5 Gonane Pharma Latest Developments
13.5 Hetero Drugs
13.5.1 Hetero Drugs Company Information
13.5.2 Hetero Drugs Efavirenz API Product Portfolios and Specifications
13.5.3 Hetero Drugs Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hetero Drugs Main Business Overview
13.5.5 Hetero Drugs Latest Developments
13.6 Laurus Labs
13.6.1 Laurus Labs Company Information
13.6.2 Laurus Labs Efavirenz API Product Portfolios and Specifications
13.6.3 Laurus Labs Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Laurus Labs Main Business Overview
13.6.5 Laurus Labs Latest Developments
13.7 Mylan
13.7.1 Mylan Company Information
13.7.2 Mylan Efavirenz API Product Portfolios and Specifications
13.7.3 Mylan Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mylan Main Business Overview
13.7.5 Mylan Latest Developments
13.8 NEWEDGE Overseas
13.8.1 NEWEDGE Overseas Company Information
13.8.2 NEWEDGE Overseas Efavirenz API Product Portfolios and Specifications
13.8.3 NEWEDGE Overseas Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 NEWEDGE Overseas Main Business Overview
13.8.5 NEWEDGE Overseas Latest Developments
13.9 SMS Pharmaceuticals
13.9.1 SMS Pharmaceuticals Company Information
13.9.2 SMS Pharmaceuticals Efavirenz API Product Portfolios and Specifications
13.9.3 SMS Pharmaceuticals Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 SMS Pharmaceuticals Main Business Overview
13.9.5 SMS Pharmaceuticals Latest Developments
13.10 Mangalam Drugs & Organics Ltd
13.10.1 Mangalam Drugs & Organics Ltd Company Information
13.10.2 Mangalam Drugs & Organics Ltd Efavirenz API Product Portfolios and Specifications
13.10.3 Mangalam Drugs & Organics Ltd Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mangalam Drugs & Organics Ltd Main Business Overview
13.10.5 Mangalam Drugs & Organics Ltd Latest Developments
13.11 Shanghai Desano Bio-Pharmaceutical
13.11.1 Shanghai Desano Bio-Pharmaceutical Company Information
13.11.2 Shanghai Desano Bio-Pharmaceutical Efavirenz API Product Portfolios and Specifications
13.11.3 Shanghai Desano Bio-Pharmaceutical Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Desano Bio-Pharmaceutical Main Business Overview
13.11.5 Shanghai Desano Bio-Pharmaceutical Latest Developments
13.12 Guangzhou Topwork Chemical
13.12.1 Guangzhou Topwork Chemical Company Information
13.12.2 Guangzhou Topwork Chemical Efavirenz API Product Portfolios and Specifications
13.12.3 Guangzhou Topwork Chemical Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Guangzhou Topwork Chemical Main Business Overview
13.12.5 Guangzhou Topwork Chemical Latest Developments
13.13 Jiangsu Zhongbang Pharmaceutical
13.13.1 Jiangsu Zhongbang Pharmaceutical Company Information
13.13.2 Jiangsu Zhongbang Pharmaceutical Efavirenz API Product Portfolios and Specifications
13.13.3 Jiangsu Zhongbang Pharmaceutical Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Jiangsu Zhongbang Pharmaceutical Main Business Overview
13.13.5 Jiangsu Zhongbang Pharmaceutical Latest Developments
13.14 Nortec Quimica
13.14.1 Nortec Quimica Company Information
13.14.2 Nortec Quimica Efavirenz API Product Portfolios and Specifications
13.14.3 Nortec Quimica Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Nortec Quimica Main Business Overview
13.14.5 Nortec Quimica Latest Developments
13.15 Globe Quimica Ltda
13.15.1 Globe Quimica Ltda Company Information
13.15.2 Globe Quimica Ltda Efavirenz API Product Portfolios and Specifications
13.15.3 Globe Quimica Ltda Efavirenz API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Globe Quimica Ltda Main Business Overview
13.15.5 Globe Quimica Ltda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Efavirenz API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Efavirenz API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 6. Global Efavirenz API Sales Market Share by Type (2018-2023)
Table 7. Global Efavirenz API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Efavirenz API Revenue Market Share by Type (2018-2023)
Table 9. Global Efavirenz API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 11. Global Efavirenz API Sales Market Share by Application (2018-2023)
Table 12. Global Efavirenz API Revenue by Application (2018-2023)
Table 13. Global Efavirenz API Revenue Market Share by Application (2018-2023)
Table 14. Global Efavirenz API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Efavirenz API Sales by Company (2018-2023) & (Kg)
Table 16. Global Efavirenz API Sales Market Share by Company (2018-2023)
Table 17. Global Efavirenz API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Efavirenz API Revenue Market Share by Company (2018-2023)
Table 19. Global Efavirenz API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Efavirenz API Producing Area Distribution and Sales Area
Table 21. Players Efavirenz API Products Offered
Table 22. Efavirenz API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Efavirenz API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Efavirenz API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Efavirenz API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Efavirenz API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Efavirenz API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Efavirenz API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Efavirenz API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Efavirenz API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Efavirenz API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Efavirenz API Sales Market Share by Country (2018-2023)
Table 35. Americas Efavirenz API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Efavirenz API Revenue Market Share by Country (2018-2023)
Table 37. Americas Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Efavirenz API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Efavirenz API Sales Market Share by Region (2018-2023)
Table 41. APAC Efavirenz API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Efavirenz API Revenue Market Share by Region (2018-2023)
Table 43. APAC Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Efavirenz API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Efavirenz API Sales Market Share by Country (2018-2023)
Table 47. Europe Efavirenz API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Efavirenz API Revenue Market Share by Country (2018-2023)
Table 49. Europe Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Efavirenz API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Efavirenz API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Efavirenz API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Efavirenz API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Efavirenz API
Table 58. Key Market Challenges & Risks of Efavirenz API
Table 59. Key Industry Trends of Efavirenz API
Table 60. Efavirenz API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Efavirenz API Distributors List
Table 63. Efavirenz API Customer List
Table 64. Global Efavirenz API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Efavirenz API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Efavirenz API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Efavirenz API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Efavirenz API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Efavirenz API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Efavirenz API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Efavirenz API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Efavirenz API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Efavirenz API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Efavirenz API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Efavirenz API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Efavirenz API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Efavirenz API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Acebright India Pharma Private Limited Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 79. Acebright India Pharma Private Limited Efavirenz API Product Portfolios and Specifications
Table 80. Acebright India Pharma Private Limited Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Acebright India Pharma Private Limited Main Business
Table 82. Acebright India Pharma Private Limited Latest Developments
Table 83. Arene Lifesciences Limited Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 84. Arene Lifesciences Limited Efavirenz API Product Portfolios and Specifications
Table 85. Arene Lifesciences Limited Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Arene Lifesciences Limited Main Business
Table 87. Arene Lifesciences Limited Latest Developments
Table 88. Dasami Lab Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 89. Dasami Lab Efavirenz API Product Portfolios and Specifications
Table 90. Dasami Lab Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Dasami Lab Main Business
Table 92. Dasami Lab Latest Developments
Table 93. Gonane Pharma Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 94. Gonane Pharma Efavirenz API Product Portfolios and Specifications
Table 95. Gonane Pharma Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Gonane Pharma Main Business
Table 97. Gonane Pharma Latest Developments
Table 98. Hetero Drugs Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 99. Hetero Drugs Efavirenz API Product Portfolios and Specifications
Table 100. Hetero Drugs Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Hetero Drugs Main Business
Table 102. Hetero Drugs Latest Developments
Table 103. Laurus Labs Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 104. Laurus Labs Efavirenz API Product Portfolios and Specifications
Table 105. Laurus Labs Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Laurus Labs Main Business
Table 107. Laurus Labs Latest Developments
Table 108. Mylan Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 109. Mylan Efavirenz API Product Portfolios and Specifications
Table 110. Mylan Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Mylan Main Business
Table 112. Mylan Latest Developments
Table 113. NEWEDGE Overseas Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 114. NEWEDGE Overseas Efavirenz API Product Portfolios and Specifications
Table 115. NEWEDGE Overseas Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. NEWEDGE Overseas Main Business
Table 117. NEWEDGE Overseas Latest Developments
Table 118. SMS Pharmaceuticals Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 119. SMS Pharmaceuticals Efavirenz API Product Portfolios and Specifications
Table 120. SMS Pharmaceuticals Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. SMS Pharmaceuticals Main Business
Table 122. SMS Pharmaceuticals Latest Developments
Table 123. Mangalam Drugs & Organics Ltd Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 124. Mangalam Drugs & Organics Ltd Efavirenz API Product Portfolios and Specifications
Table 125. Mangalam Drugs & Organics Ltd Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Mangalam Drugs & Organics Ltd Main Business
Table 127. Mangalam Drugs & Organics Ltd Latest Developments
Table 128. Shanghai Desano Bio-Pharmaceutical Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Desano Bio-Pharmaceutical Efavirenz API Product Portfolios and Specifications
Table 130. Shanghai Desano Bio-Pharmaceutical Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 131. Shanghai Desano Bio-Pharmaceutical Main Business
Table 132. Shanghai Desano Bio-Pharmaceutical Latest Developments
Table 133. Guangzhou Topwork Chemical Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 134. Guangzhou Topwork Chemical Efavirenz API Product Portfolios and Specifications
Table 135. Guangzhou Topwork Chemical Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 136. Guangzhou Topwork Chemical Main Business
Table 137. Guangzhou Topwork Chemical Latest Developments
Table 138. Jiangsu Zhongbang Pharmaceutical Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 139. Jiangsu Zhongbang Pharmaceutical Efavirenz API Product Portfolios and Specifications
Table 140. Jiangsu Zhongbang Pharmaceutical Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 141. Jiangsu Zhongbang Pharmaceutical Main Business
Table 142. Jiangsu Zhongbang Pharmaceutical Latest Developments
Table 143. Nortec Quimica Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 144. Nortec Quimica Efavirenz API Product Portfolios and Specifications
Table 145. Nortec Quimica Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 146. Nortec Quimica Main Business
Table 147. Nortec Quimica Latest Developments
Table 148. Globe Quimica Ltda Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 149. Globe Quimica Ltda Efavirenz API Product Portfolios and Specifications
Table 150. Globe Quimica Ltda Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 151. Globe Quimica Ltda Main Business
Table 152. Globe Quimica Ltda Latest Developments
Table 1. Efavirenz API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Efavirenz API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 6. Global Efavirenz API Sales Market Share by Type (2018-2023)
Table 7. Global Efavirenz API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Efavirenz API Revenue Market Share by Type (2018-2023)
Table 9. Global Efavirenz API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 11. Global Efavirenz API Sales Market Share by Application (2018-2023)
Table 12. Global Efavirenz API Revenue by Application (2018-2023)
Table 13. Global Efavirenz API Revenue Market Share by Application (2018-2023)
Table 14. Global Efavirenz API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Efavirenz API Sales by Company (2018-2023) & (Kg)
Table 16. Global Efavirenz API Sales Market Share by Company (2018-2023)
Table 17. Global Efavirenz API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Efavirenz API Revenue Market Share by Company (2018-2023)
Table 19. Global Efavirenz API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Efavirenz API Producing Area Distribution and Sales Area
Table 21. Players Efavirenz API Products Offered
Table 22. Efavirenz API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Efavirenz API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Efavirenz API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Efavirenz API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Efavirenz API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Efavirenz API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Efavirenz API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Efavirenz API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Efavirenz API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Efavirenz API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Efavirenz API Sales Market Share by Country (2018-2023)
Table 35. Americas Efavirenz API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Efavirenz API Revenue Market Share by Country (2018-2023)
Table 37. Americas Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Efavirenz API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Efavirenz API Sales Market Share by Region (2018-2023)
Table 41. APAC Efavirenz API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Efavirenz API Revenue Market Share by Region (2018-2023)
Table 43. APAC Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Efavirenz API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Efavirenz API Sales Market Share by Country (2018-2023)
Table 47. Europe Efavirenz API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Efavirenz API Revenue Market Share by Country (2018-2023)
Table 49. Europe Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Efavirenz API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Efavirenz API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Efavirenz API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Efavirenz API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Efavirenz API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Efavirenz API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Efavirenz API
Table 58. Key Market Challenges & Risks of Efavirenz API
Table 59. Key Industry Trends of Efavirenz API
Table 60. Efavirenz API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Efavirenz API Distributors List
Table 63. Efavirenz API Customer List
Table 64. Global Efavirenz API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Efavirenz API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Efavirenz API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Efavirenz API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Efavirenz API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Efavirenz API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Efavirenz API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Efavirenz API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Efavirenz API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Efavirenz API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Efavirenz API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Efavirenz API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Efavirenz API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Efavirenz API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Acebright India Pharma Private Limited Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 79. Acebright India Pharma Private Limited Efavirenz API Product Portfolios and Specifications
Table 80. Acebright India Pharma Private Limited Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Acebright India Pharma Private Limited Main Business
Table 82. Acebright India Pharma Private Limited Latest Developments
Table 83. Arene Lifesciences Limited Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 84. Arene Lifesciences Limited Efavirenz API Product Portfolios and Specifications
Table 85. Arene Lifesciences Limited Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Arene Lifesciences Limited Main Business
Table 87. Arene Lifesciences Limited Latest Developments
Table 88. Dasami Lab Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 89. Dasami Lab Efavirenz API Product Portfolios and Specifications
Table 90. Dasami Lab Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Dasami Lab Main Business
Table 92. Dasami Lab Latest Developments
Table 93. Gonane Pharma Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 94. Gonane Pharma Efavirenz API Product Portfolios and Specifications
Table 95. Gonane Pharma Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Gonane Pharma Main Business
Table 97. Gonane Pharma Latest Developments
Table 98. Hetero Drugs Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 99. Hetero Drugs Efavirenz API Product Portfolios and Specifications
Table 100. Hetero Drugs Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Hetero Drugs Main Business
Table 102. Hetero Drugs Latest Developments
Table 103. Laurus Labs Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 104. Laurus Labs Efavirenz API Product Portfolios and Specifications
Table 105. Laurus Labs Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Laurus Labs Main Business
Table 107. Laurus Labs Latest Developments
Table 108. Mylan Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 109. Mylan Efavirenz API Product Portfolios and Specifications
Table 110. Mylan Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Mylan Main Business
Table 112. Mylan Latest Developments
Table 113. NEWEDGE Overseas Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 114. NEWEDGE Overseas Efavirenz API Product Portfolios and Specifications
Table 115. NEWEDGE Overseas Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. NEWEDGE Overseas Main Business
Table 117. NEWEDGE Overseas Latest Developments
Table 118. SMS Pharmaceuticals Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 119. SMS Pharmaceuticals Efavirenz API Product Portfolios and Specifications
Table 120. SMS Pharmaceuticals Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. SMS Pharmaceuticals Main Business
Table 122. SMS Pharmaceuticals Latest Developments
Table 123. Mangalam Drugs & Organics Ltd Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 124. Mangalam Drugs & Organics Ltd Efavirenz API Product Portfolios and Specifications
Table 125. Mangalam Drugs & Organics Ltd Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Mangalam Drugs & Organics Ltd Main Business
Table 127. Mangalam Drugs & Organics Ltd Latest Developments
Table 128. Shanghai Desano Bio-Pharmaceutical Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Desano Bio-Pharmaceutical Efavirenz API Product Portfolios and Specifications
Table 130. Shanghai Desano Bio-Pharmaceutical Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 131. Shanghai Desano Bio-Pharmaceutical Main Business
Table 132. Shanghai Desano Bio-Pharmaceutical Latest Developments
Table 133. Guangzhou Topwork Chemical Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 134. Guangzhou Topwork Chemical Efavirenz API Product Portfolios and Specifications
Table 135. Guangzhou Topwork Chemical Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 136. Guangzhou Topwork Chemical Main Business
Table 137. Guangzhou Topwork Chemical Latest Developments
Table 138. Jiangsu Zhongbang Pharmaceutical Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 139. Jiangsu Zhongbang Pharmaceutical Efavirenz API Product Portfolios and Specifications
Table 140. Jiangsu Zhongbang Pharmaceutical Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 141. Jiangsu Zhongbang Pharmaceutical Main Business
Table 142. Jiangsu Zhongbang Pharmaceutical Latest Developments
Table 143. Nortec Quimica Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 144. Nortec Quimica Efavirenz API Product Portfolios and Specifications
Table 145. Nortec Quimica Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 146. Nortec Quimica Main Business
Table 147. Nortec Quimica Latest Developments
Table 148. Globe Quimica Ltda Basic Information, Efavirenz API Manufacturing Base, Sales Area and Its Competitors
Table 149. Globe Quimica Ltda Efavirenz API Product Portfolios and Specifications
Table 150. Globe Quimica Ltda Efavirenz API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 151. Globe Quimica Ltda Main Business
Table 152. Globe Quimica Ltda Latest Developments
LIST OF FIGURES
Figure 1. Picture of Efavirenz API
Figure 2. Efavirenz API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Efavirenz API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Efavirenz API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Efavirenz API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Efavirenz API Sales Market Share by Type in 2022
Figure 12. Global Efavirenz API Revenue Market Share by Type (2018-2023)
Figure 13. Efavirenz API Consumed in Oral Solution
Figure 14. Global Efavirenz API Market: Oral Solution (2018-2023) & (Kg)
Figure 15. Efavirenz API Consumed in Capsules
Figure 16. Global Efavirenz API Market: Capsules (2018-2023) & (Kg)
Figure 17. Efavirenz API Consumed in Tablets
Figure 18. Global Efavirenz API Market: Tablets (2018-2023) & (Kg)
Figure 19. Efavirenz API Consumed in Others
Figure 20. Global Efavirenz API Market: Others (2018-2023) & (Kg)
Figure 21. Global Efavirenz API Sales Market Share by Application (2022)
Figure 22. Global Efavirenz API Revenue Market Share by Application in 2022
Figure 23. Efavirenz API Sales Market by Company in 2022 (Kg)
Figure 24. Global Efavirenz API Sales Market Share by Company in 2022
Figure 25. Efavirenz API Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Efavirenz API Revenue Market Share by Company in 2022
Figure 27. Global Efavirenz API Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Efavirenz API Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Efavirenz API Sales 2018-2023 (Kg)
Figure 30. Americas Efavirenz API Revenue 2018-2023 ($ Millions)
Figure 31. APAC Efavirenz API Sales 2018-2023 (Kg)
Figure 32. APAC Efavirenz API Revenue 2018-2023 ($ Millions)
Figure 33. Europe Efavirenz API Sales 2018-2023 (Kg)
Figure 34. Europe Efavirenz API Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Efavirenz API Sales 2018-2023 (Kg)
Figure 36. Middle East & Africa Efavirenz API Revenue 2018-2023 ($ Millions)
Figure 37. Americas Efavirenz API Sales Market Share by Country in 2022
Figure 38. Americas Efavirenz API Revenue Market Share by Country in 2022
Figure 39. Americas Efavirenz API Sales Market Share by Type (2018-2023)
Figure 40. Americas Efavirenz API Sales Market Share by Application (2018-2023)
Figure 41. United States Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Efavirenz API Sales Market Share by Region in 2022
Figure 46. APAC Efavirenz API Revenue Market Share by Regions in 2022
Figure 47. APAC Efavirenz API Sales Market Share by Type (2018-2023)
Figure 48. APAC Efavirenz API Sales Market Share by Application (2018-2023)
Figure 49. China Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Efavirenz API Sales Market Share by Country in 2022
Figure 57. Europe Efavirenz API Revenue Market Share by Country in 2022
Figure 58. Europe Efavirenz API Sales Market Share by Type (2018-2023)
Figure 59. Europe Efavirenz API Sales Market Share by Application (2018-2023)
Figure 60. Germany Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Efavirenz API Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Efavirenz API Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Efavirenz API Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Efavirenz API Sales Market Share by Application (2018-2023)
Figure 69. Egypt Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Efavirenz API in 2022
Figure 75. Manufacturing Process Analysis of Efavirenz API
Figure 76. Industry Chain Structure of Efavirenz API
Figure 77. Channels of Distribution
Figure 78. Global Efavirenz API Sales Market Forecast by Region (2024-2029)
Figure 79. Global Efavirenz API Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Efavirenz API Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Efavirenz API Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Efavirenz API Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Efavirenz API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Efavirenz API
Figure 2. Efavirenz API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Efavirenz API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Efavirenz API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Efavirenz API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Efavirenz API Sales Market Share by Type in 2022
Figure 12. Global Efavirenz API Revenue Market Share by Type (2018-2023)
Figure 13. Efavirenz API Consumed in Oral Solution
Figure 14. Global Efavirenz API Market: Oral Solution (2018-2023) & (Kg)
Figure 15. Efavirenz API Consumed in Capsules
Figure 16. Global Efavirenz API Market: Capsules (2018-2023) & (Kg)
Figure 17. Efavirenz API Consumed in Tablets
Figure 18. Global Efavirenz API Market: Tablets (2018-2023) & (Kg)
Figure 19. Efavirenz API Consumed in Others
Figure 20. Global Efavirenz API Market: Others (2018-2023) & (Kg)
Figure 21. Global Efavirenz API Sales Market Share by Application (2022)
Figure 22. Global Efavirenz API Revenue Market Share by Application in 2022
Figure 23. Efavirenz API Sales Market by Company in 2022 (Kg)
Figure 24. Global Efavirenz API Sales Market Share by Company in 2022
Figure 25. Efavirenz API Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Efavirenz API Revenue Market Share by Company in 2022
Figure 27. Global Efavirenz API Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Efavirenz API Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Efavirenz API Sales 2018-2023 (Kg)
Figure 30. Americas Efavirenz API Revenue 2018-2023 ($ Millions)
Figure 31. APAC Efavirenz API Sales 2018-2023 (Kg)
Figure 32. APAC Efavirenz API Revenue 2018-2023 ($ Millions)
Figure 33. Europe Efavirenz API Sales 2018-2023 (Kg)
Figure 34. Europe Efavirenz API Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Efavirenz API Sales 2018-2023 (Kg)
Figure 36. Middle East & Africa Efavirenz API Revenue 2018-2023 ($ Millions)
Figure 37. Americas Efavirenz API Sales Market Share by Country in 2022
Figure 38. Americas Efavirenz API Revenue Market Share by Country in 2022
Figure 39. Americas Efavirenz API Sales Market Share by Type (2018-2023)
Figure 40. Americas Efavirenz API Sales Market Share by Application (2018-2023)
Figure 41. United States Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Efavirenz API Sales Market Share by Region in 2022
Figure 46. APAC Efavirenz API Revenue Market Share by Regions in 2022
Figure 47. APAC Efavirenz API Sales Market Share by Type (2018-2023)
Figure 48. APAC Efavirenz API Sales Market Share by Application (2018-2023)
Figure 49. China Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Efavirenz API Sales Market Share by Country in 2022
Figure 57. Europe Efavirenz API Revenue Market Share by Country in 2022
Figure 58. Europe Efavirenz API Sales Market Share by Type (2018-2023)
Figure 59. Europe Efavirenz API Sales Market Share by Application (2018-2023)
Figure 60. Germany Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Efavirenz API Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Efavirenz API Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Efavirenz API Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Efavirenz API Sales Market Share by Application (2018-2023)
Figure 69. Egypt Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Efavirenz API Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Efavirenz API in 2022
Figure 75. Manufacturing Process Analysis of Efavirenz API
Figure 76. Industry Chain Structure of Efavirenz API
Figure 77. Channels of Distribution
Figure 78. Global Efavirenz API Sales Market Forecast by Region (2024-2029)
Figure 79. Global Efavirenz API Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Efavirenz API Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Efavirenz API Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Efavirenz API Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Efavirenz API Revenue Market Share Forecast by Application (2024-2029)
